Clinical severity and epithelial endotypes in chronic rhinosinusitis

International Forum of Allergy and Rhinology

Volumn 3, Issue 2, 2013, Pages 121-128

  Lam, Matthew ^a,b   Hull, Laura ^a,b   Mclachlan, Rohan ^a   Snidvongs, Kornkiat ^c,d   Chin, David ^e   Pratt, Ellie ^f   Kalish, Larry ^g   Sacks, Raymond ^c,f   Earls, Peter ^e   Sewell, William ^a,b   Harvey, Richard J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Interleukin 25; Interleukin 33; MRNA; Nose; Polyps; QPCR; Rhinitis; Sinusitis; Thymic stromal lymphopoietin

Indexed keywords

EOTAXIN 3; INTERLEUKIN 25; INTERLEUKIN 33; MESSENGER RNA; THYMIC STROMAL LYMPHOPOIETIN;

ADULT; ARTICLE; ATOPY; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPY; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; NOSE MUCOSA; NOSE POLYP; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPTOM; TH2 CELL;

CASE-CONTROL STUDIES; CHEMOKINES, CC; CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; POLYMERASE CHAIN REACTION; RHINITIS; RNA, MESSENGER; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873887096     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21082     Document Type: Article

References (45)

1. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European Position Paper on Rhinosinusitis and Nasal Polyps 2007. Rhinology. 2007;20:1-136.
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:155-212.
3. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104-109.
4. Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L. Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope.2004;114:1895-1905.
5. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-1289.
6. Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008;226:172-190.
7. Paul WE, Zhu J. How are TH2-type immune responses initiated and amplified. Nat Rev Immunol. 2010;10:225-235.
8. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15:985-995.
9. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-490.
10. Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007;204:1837-1847.
11. Zhou B, Comeau MR, Thibaut De Smedt H, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol. 2005;6:1047-1053.
12. Reh DD, Wang Y, Ramanathan M Jr, Lane AP. Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am J Rhinol Allergy. 2011;24:105-109.
13. Boita M, Garzaro M, Raimondo L, et al. The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps. Int J Immunopathol Pharmacol. 2011;24:761-
14. Kimura S, Pawankar R, Mori S, et al. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011;3:186-193.
15. Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today. 2000;6:20-27.
16. Olze H, Förster U, Zuberbier T, Morawietz L, Luger E. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology. 2006;44:145-150.
17. Yao T, Kojima Y, Koyanagi A, et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope. 2009;119:1053-1059.
18. Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg. 2008;139:137-
19. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34:447-454.
20. Lund V, Mackay I. Staging in rhinosinusitis. Rhinology. 1993;3:183.
21. Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol. 2010;11:577-584.
22. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355-360.
23. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;(3):129:S1-S32.
24. Tosun F, Arslan HH, Karslioglu Y, Deveci MS, Durmaz A. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Ann Otol Rhinol Laryngol. 2010;119:455-459.
25. Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2009;141:454-461.
26. Soler ZM, Sauer D, Mace J, Smith TL. Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery. Otolaryngol Head Neck Surg. 2010;(1):142:64-71.
27. Snidvongs K, Lam M, Sacks R, et al. Structured histopathology profiling of chronic rhinosinusitis in routine practice. Int Forum Allergy Rhinol. (in press).
28. Sanderson C. Interleukin-5, eosinophils, and disease. Blood. 1992;79:3101-3109.
29. Lüthi AU, Cullen SP, McNeela EA, et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity. 2009;31:84-98.
30. Krouse JH. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg. 2000;123:389-392.
31. Gibson P, Denburg J, Dolovich J, Ramsdale E, Hargreave F. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989;333:1346-1348.
32. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536.
33. Berrettini S, Carabelli A, Sellari Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy. 1999;54:242-248.
34. Pant H, Kette FE, Smith WB, Macardle PJ, Wormald PJ. Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity. Laryngoscope. 2006;116:1241-1247.
35. Hidir Y, Tosun F, Saracli MA, Gunal A, Gulec M, Yetiser S. Rate of allergic fungal etiology of chronic rhinosinusitis in Turkish population. Eur Arch Otorhinolaryngol. 2008;265:415-419.
36. Lane AP, Pine HS, Pillsbury HC. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg. 2001;124:9.
37. Marple B, Newcomer M, Schwade N, Mabry R. Natural history of allergic fungal rhinosinusitis: a 4-to 10-year follow-up. Otolaryngol Head Neck Surg. 2002;127:361.
38. Deal RT, Kountakis SE. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope. 2004;114:1932-1935.
39. Bachert C, Patou J, Cauwenberge PV. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol. 2006;6:29.
40. Stewart MG, Jenkins HA, Coker NJ, Jerger JF, Loiselle LH. Development of a new outcomes instrument for conductive hearing loss. Am J Otol. 1997;18:413-420.
41. Sullivan M. The new subjective medicine: taking the patient's point of view on health care and health. Soc Sci Med. 2003;56:1595-1604.
42. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis. 1986;174:736-742.
43. Sullivan M, LaCroix A, Baum C, et al. Coronary disease severity and functional impairment: how strong is the relation. J Am Geriatr Soc. 1996;44:1461-1465.
44. Davis MA, Ettinger WH, Neuhaus JM, Barclay JD, Segal MR. Correlates of knee pain among US adults with and without radiographic knee osteoarthritis. J Rheumatol. 1992;19:1943-1949.
45. Stewart MG, Smith TL. Objective versus subjective outcomes assessment in rhinology. Am J Rhinol. 2005;19:529-535.